William Bonello - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: Chief Financial Officer
Issuer ticker: NEO
Reported as of: 01 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2022, 18:57:26 UTC
Prior SEC filing: 30 Dec 2021
Next SEC filing: 09 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Halley E. Gilbert, Attorney-in-Fact

Key filing fact

William Bonello filed Form 4 for NEOGENOMICS INC (NEO) on 03 Mar 2022.

Key facts

This page summarizes William Bonello's Form 4 filing for NEOGENOMICS INC (NEO).
4 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 03 Mar 2022, 18:57.

Change

Previous filing in this sequence was filed on 30 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Award

Transaction value: $0
Shares: +40,869
Change %: +66%
Price: $0.000000
Shares after: 102,742
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F1

NEO transaction

Common Stock

Tax liability

Transaction value: $0
Shares: -397
Change %: -0.39%
Price: $0.000000
Shares after: 102,345
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F2

NEO transaction

Common Stock

Tax liability

Transaction value: $0
Shares: -620
Change %: -0.61%
Price: $0.000000
Shares after: 101,725
Date: 02 Mar 2022
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +99,772
Change %
Price: $0.000000
Shares after: 99,772
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 99,772
Exercise price: $21.41
Footnotes: F9

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,727
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,727
Exercise price: $7.52
Footnotes: F4

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 45,370
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,370
Exercise price: $8.03
Footnotes: F5

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 41,167
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,167
Exercise price: $19.60
Footnotes: F6

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,514
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,514
Exercise price: $28.33
Footnotes: F7

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 24,619
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,619
Exercise price: $53.17
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

Footnote F2

Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock.

Footnote F3

Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.

Footnote F4

On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

Footnote F5

On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

Footnote F6

On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F7

On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F8

On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F9

On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.

SEC remarks

Exhibit List: Exhibit 24 - Limited Power Of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .